Please assess the completion status of the following clinical trial:

Trial Title: Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Recruitment of patients at the Johns Hopkins Regional Burn Center for study will be based upon the following clinical criteria:~* Second degree scald burn of 10 cm2~* Age between 14 to 75 years~* Burn area equal or less than 95% of Burn Surface Area (BSA)~* Body temperature between 98.5 and 101 degree F~* Informed consent for enrolment into study~* Spanish speaking patients will be included when we have a Spanish consent form available.~Exclusion Criteria:~* First and third degree burn wounds~* Hemodynamic instability (SBP below 100, Heart Rate (HR) over 100, urine output less than 30 ml/hour~* Area of burn over 20% of BSA~* Hypothermia T\<98.5 or Hyperthermia T\>101 degree F~* Urine output less than 30 ml/hour~* Serum albumin less than 3 mg/ml.~* Subjects weighing less than 50 kg.

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Healthy volunteers (Type: SHAM_COMPARATOR): Healthy volunteers with no burn wounds Volunteers donate blood that will be studied in comparison to patients who have sustained burns. The circulating bone marrow stem cells will be counted and compared to the levels in burn patients. Six 12 ml tubes will be taken for the study. You will not be compensated. But you will be helping to advance science if you join the study.
- Burn volunteer (Type: ACTIVE_COMPARATOR): To recruit burn wound patients with defined clinical criteria for study. A second-degree burn of at least 10 cm2 to up to 95% BSA; age = 14-75 years; BP \> 100 mm Hg systolic; heart rate \< 100 beats/minute; urine output \> 30 ml/hour; area of burn \< 20% of BSA; body temperature = 98.5-101 degrees Fahrenheit; serum albumin \> 3 mg/ml; and informed consent. We will also obtain a history regarding the presence or absence of risk factors that may affect CAC numbers: hypertension \> 1 year; smoking \> 2 pack-years or within the last year; diabetes mellitus; and family history of premature coronary artery disease (men \< 55 and women \< 65 years of age).Six 12 ml tubes will be taken at 5 time points

Based on this trial design, predict the completion outcome and termination type (if applicable).